Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

59.3K
Overview
59.3K
Antimicrobial Proteins01:23

Antimicrobial Proteins

12.9K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.9K
Transduction01:16

Transduction

1.1K
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
1.1K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.2K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.2K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

479
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
479
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

763
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
763

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ATP-sensitive peptide-based coacervates for intracellular delivery of therapeutic oligonucleotides.

Frontiers in molecular biosciences·2026
Same author

Duplication of the Antistasin-Like Structure Resulted in a New Anticoagulant Protein in the Medicinal Leech.

Biomolecules·2026
Same author

Beyond Direct Fibrinolysis: Novel Approaches to Thrombolysis.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Production, Purification, and Characterization of a Novel Cysteine-Rich Anticoagulant from the Medicinal Leech and the Functional Role of Its C-Terminal Motif.

Biomolecules·2025
Same author

Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability.

International journal of molecular sciences·2025
Same author

G4 Oligonucleotide-Based Chaperones of Heterogeneous Nuclear Ribonucleoprotein A1.

International journal of molecular sciences·2025

Related Experiment Video

Updated: Jan 10, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.0K

Development of New Antimicrobial Peptides by Directional Selection.

Ekaterina Grafskaia1, Pavel Bobrovsky1,2, Daria Kharlampieva1

  • 1Laboratory of Genetic Engineering, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia.

Antibiotics (Basel, Switzerland)
|November 27, 2025
PubMed
Summary

Researchers developed new antimicrobial peptides by mutating existing ones to combat antibiotic resistance. Some mutants showed reduced toxicity and broader activity against bacteria like E. coli and B. subtilis.

Keywords:
Hm-AMP2antibacterial activityantimicrobial peptidececropinexpression systemlibrarymelittinmutagenesis

More Related Videos

Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli
09:01

Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli

Published on: March 16, 2011

31.1K
Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.6K

Related Experiment Videos

Last Updated: Jan 10, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.0K
Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli
09:01

Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli

Published on: March 16, 2011

31.1K
Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.6K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Rising global antibiotic resistance necessitates novel antimicrobial agents.
  • Antimicrobial peptides (AMPs) are promising candidates due to their role in innate immunity.
  • Developing enhanced AMPs requires innovative strategies like mutagenesis and screening.

Purpose of the Study:

  • To develop novel therapeutic peptides with improved properties.
  • To achieve this through mutagenesis of natural AMPs and high-throughput screening.
  • To identify variants with enhanced antimicrobial activity and reduced cytotoxicity.

Main Methods:

  • Constructed mutant libraries of melittin, cecropin, and Hm-AMP2 using mutagenesis.
  • Assessed antimicrobial activity against E. coli and B. subtilis using bacterial growth kinetics and droplet serial dilution assays.
  • Determined cytotoxicity in human Expi293F cells and calculated therapeutic index.

Main Results:

  • Melittin mutants (MR1P7, MR1P8) exhibited reduced cytotoxicity while maintaining antimicrobial activity.
  • Cecropin mutants showed varied efficacy; some gained activity against Gram-positive bacteria.
  • Hm-AMP2 mutants demonstrated retained or enhanced efficacy against B. subtilis with low cytotoxicity.

Conclusions:

  • The mutagenesis strategy successfully generated peptides with improved therapeutic profiles.
  • Identified variants possess reduced toxicity or broader antimicrobial spectrum.
  • This approach aids in discovering novel bioactive peptides to combat antibiotic-resistant pathogens.